<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There are few reports about the occurrence of hepatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> after BMT for severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) </plain></SENT>
<SENT sid="1" pm="."><plain>We prospectively studied 17 patients with SAA after allogeneic BMT for the occurrence and severity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Plasma levels of protein C, protein S, antithrombin III, vWF, t-PA and PAI-1 were determined before preparative chemotherapy, on the day of marrow infusion, and on days 7, 14 and 21 </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> occurred in seven patients (41.2%) at a median of day 1 (range, day -2 to 15) </plain></SENT>
<SENT sid="4" pm="."><plain>Five had mild, and two moderate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Platelet transfusion requirements were higher in the patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The plasma levels of natural <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> such as protein C, free protein S and antithrombin III decreased significantly on day 0 from the baseline levels </plain></SENT>
<SENT sid="7" pm="."><plain>Plasma levels of t-PA, PAI-1 and vWF increased significantly in the early post-transplant period compared to the baseline levels </plain></SENT>
<SENT sid="8" pm="."><plain>The mean plasma levels of t-PA on day 7 (P = 0.016) and PAI-1 on days 0 and 7 (P = 0.016, 0.032) were higher in the patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>In summary, we observed <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> and a high incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> after allogeneic BMT for SAA </plain></SENT>
<SENT sid="10" pm="."><plain>Levels of t-PA and PAI-1 were significantly higher in the patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> after BMT </plain></SENT>
</text></document>